Past Clinical Trials

The Melanoma Unit has participated in a number of important clinical trials in recent years including:

  • MSLT-1 Sentinel Node Biopsy trial
  • MSLT-2 Sentinel Node Biopsy trial
  • Cancervax, Immunotherapy vaccine trial
  • Intergroup adjuvant radiotherapy trial for resected Stage IIIB/C melanoma
  • ECOG 1697 Interferon trial
  • Ludwig NY-ESO-1 vaccine trial
  • BRIM-3 BRAF inhibitor trial
  • Checkmate